First Biosimilar Drug Approved
Zarxio is ‘highly similar’ to long-sanctioned cancer drugContinue Reading
Zarxio is ‘highly similar’ to long-sanctioned cancer drugContinue Reading
Most often these illnesses affect people with weakened immune systemsContinue Reading
Most often these illnesses affect people with weakened immune systemsContinue Reading
Zarxio approval paves way for less expensive cutting-edge medications, experts sayContinue Reading
A complication of kidney failure
Continue Reading
People with moderate to severe depression saw improved circulatory outcomes with antidepressantsContinue Reading
High-risk situation led doctor to get immunization; no serious illness developedContinue Reading
Large Finnish study found a nearly 50 percent increase in people taking cholesterol-lowering drugsContinue Reading
But study group taking digoxin may have been sicker overall, cardiologist notesContinue Reading
But experts agree more research is needed, especially in light of FDA warningContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.